Date
Wednesday, April 25, 2007
Time8:00am - 7:30pm
Location
University of Pennsylvania
Philadelphia, Pennsylvania
Moderators
Director
Institute for Translational Medicine and Therapeutics
University of Pennsylvania School of Medicine
Associate Director
Institute for Translational Medicine and Therapeutics
University of Pennsylvania School of Medicine
Arthur Rubenstein, MBBCh
Executive Vice President, University of Pennsylvania for the Health System and Dean of the School of Medicine
Speakers
Edward T. Bullmore, PhD
Professor, Department of Psychiatry, University of Cambridge
Vice President for Experimental Medicine, Translational Medicine and Genetics Division, GlaxoSmithKline Research and Development
Brain Functional Networks
Mark Caulfield, MBBS, MD, FRCP
Director, William Harvey Research Institute, Barts and the London Queen Mary's School of Medicine and Dentistry
Advances in Genetics of Hypertension
James H. Eberwine, PhD
Professor, Interim Co-Director, Penn Genomics Institute, Departments of Pharmacology and Psychiatry, University of Pennsylvania Medical Center
Genomics, Proteomics and Functional Genomics Platforms that Facilitate Personalized Medicine
William Evans, PharmD
Director and CEO, St. Jude Children's Research Hospital, Memphis
Cancer Pharmacogenomics: Childhood Leukemia as a Model
Peter Ghazal, PhD
Director, Scottish Centre for Genomic Technology and Informatics, University of Edinburgh Medical School
Systems Biology
Eli Gilboa, PhD
Dodson Professor of Microbiology and Immunology, Director, Dodson Interdisciplinary Immunotherapy Institute, Co-leader, Tumor Immunology Research Program, UM/Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine
mRNA Based Personalization of Vaccine Development
Geoffrey S. Ginsburg, MD, PhD
Director, Center for Genomic Medicine, Institute for Genome Sciences & Policy Professor of Medicine and Pathology, Duke University
Programs in Personalized Medicine Built on Genomics
Hakon Hakonarson, MD, PhD
Director, Center for Applied Genomics, Children's Hospital of Philadelphia
High Throughput Applied Human Genomics
John B. Hogenesch, PhD
Associate Professor of Pharmacology, ITMAT, University of Pennsylvania School of Medicine
Cell Based Screening Approaches in Characterization of Mammalian Gene Function
Calum Macrae, MD, PhD
Assistant Professor of Medicine, Harvard Medical School and Cardiovascular Research Center, Massachusetts General Hospital
High Throughput Screening in Zebrafish
Jerald P. Radich, MD
Member, Clinical Research Division, Medical Director, Research Trials Office, Fred Hutchinson Cancer Research Center
Individualization of Therapy in the Leukemias
Eric Schadt, PhD
Senior Scientific Director, Genetics, Rosetta Inpharmatics/Merck
Mapping the Genetic Architecture of Gene Expression in Human Populations to Elucidate Variations in Drug Response
Richard Weinshilboum, MD
Mary Lou and John H. Dasburg Professor in Cancer Genomics Research, Chair, Division of Clinical Pharmacology
Professor of Molecular Pharmacology & Experimental Therapeutics and Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota
The NIH Pharmacogenetics Research Network
H. Steven Wiley, PhD
Director, Biomolecular Systems Initiative, Pacific Northwest National Laboratory
Systems Biology and Cancer
Session Chairs
Ian A. Blair, PhD
A. N. Richards Professor of Pharmacology, Director, Program in Systems Biology, ITMAT, University of Pennsylvania School of Medicine
Christopher Bowe
U.S. Healthcare Correspondent, Financial Times
Arthur Caplan, PhD
Chair, Department of Bioethics, University of Pennsylvania
C. Thomas Caskey, MD, FACP
Chief Operating Officer & CEO-Elect/Director-Elect, The Brown Foundation Institute of Molecular Medicine
Executive Vice President for Molecular Medicine & Genetics, The University of Texas Health Science Center at Houston
Stacey Gabriel, PhD
Director, Genetic Analysis Platform, the Broad Institute
Pete Kirkpatrick, PhD
Chief Editor, Nature Reviews Drug Discovery
Larry J. Kricka, DPhil, FACB, CChem, FRSC, FRCPath
Professor of Pathology and Laboratory Medicine, Director of General Chemistry, Hospital of the University of Pennsylvania
Stephen Prescott, MD
President, Oklahoma Medical Research Foundation
Roundtable Panelists
Arthur Caplan, PhD
Chair, Department of Bioethics, University of Pennsylvania
Getting Kind of Personal: Ethics, Personalized Medicine and Genetic Discrimination
Barry Coller, MD
Physician in Chief, David Rockefeller Professor of Medicine, Rockefeller University
Should Antiplatelet Therapy be Personalized?
Rory Collins, FRCP, FmedSci
Principal Investigator and Chief Executive, UK Biobank
Need for Large-Scale Population Studies
Alastair JJ Wood, MD
Managing Director, Symphony Capital
Professor of Medicine, Professor of Pharmacology, Cornell Medical School NYC
Getting Personal--What do we need to know?
Co-Sponsored by the Institute for Translational Medicine and Therapeutics at The University of Pennsylvania School of Medicine, and The Applera Charitable Foundation in Celebration of the Applied Biosystems 25th Anniversary